Bronchoscopy Market: Current Analysis and Forecast (2022-2028)

A bronchoscope is a device that is used for performing the most common interventional pulmonology procedure called bronchoscopy. It consists of a hollow metal tube or a thinner tube with an attached fiberoptic or video camera for transmitting the image and is commonly used during the endoscopic examination, diagnosis, and treatment of airways and tracheobronchial tree. The growing adoption of bronchoscopy devices can be attributed to the rising prevalence of various respiratory diseases. Some of the most common respiratory diseases include lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive Pulmonary Disease (COPD). According to the World Health Organization, on 20 May 2022, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. This in turn is driving the demand for bronchoscopies to detect and treat lung cancers and above mentioned disorders.

The Bronchoscopy Market is expected to grow at a steady rate of around 7% CAGR owing to the growing demand for the minimally invasive procedure which is driving the adoption of bronchoscopy devices. Therefore, the growing technological advancement and frequent product launches in the market. For instance, in April 2021, Olympus announced the addition to its U.S. bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures.

Based on product type, the market is segmented into rigid bronchoscopes, flexible bronchoscopes, and others. Amon these, flexible bronchoscopes held a significant share of the market in 2021. This is mainly due to the growing adoption of a flexible type of bronchoscope as they are less expensive and is much easier to change the position inside the bronchus thus enabling it to give a clear image. As per the National Institute of Health, in 2022, Flexible bronchoscopy is commonly used for lung cancer diagnosis and mediastinal staging utilizing endobronchial ultrasound.

On the basis of product usage, the market is categorized into disposable equipment, and reusable equipment. Among these, disposable equipment is expected to grow with a significant CAGR during the forecast period. This is widely used for the detection of chronic obstructive Pulmonary Disease (COPD), lung infections, tumors, bronchial stenosis, and bronchitis. For instance, in August 2021, Boston Scientific Corporation received U.S. FDA 510(k) clearance for the EXALT Model B Single-Use Bronchoscope, designed for use in bedside procedures within the intensive care unit (ICU) and operating room.

Based on application, the bronchoscopy market is bifurcated into bronchial treatment, and bronchial diagnosis. Among these, bronchial diagnosis is expected to grow with a significant CAGR during the forecast period. This is mainly due to the fact that bronchoscopy is the greatest technique for diagnosing bronchial lesions. This segment is widely used for diagnosis for cut or rupture of the trachea or bronchi in chest trauma.

Based on end user, the bronchoscopy market is segmented into hospitals, ambulatory surgical centers, clinics, and others. Among these, hospitals held a significant share of the market in 2021. This is mainly due to the growing utilization of these products in hospitals as they have advanced and well-established healthcare infrastructure. In addition, the increasing preference of patients for hospital-based procedures, the availability of skilled healthcare professionals, and favorable reimbursement scenarios are some of the prominent factors boosting the growth of this segment.

For a better understanding of the market adoption of the bronchoscopy industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of the respiratory disease. According to the National Institute of Health, in 2022, China accounted for almost 25% of all Chronic Obstructive Pulmonary Disease (COPD) cases globally. The key players are actively investing in research and development, which is also having a positive impact on the market's growth. For instance, in May 2021, PENTAX Medical headquater in Japan, launched their new single-use bronchoscope named the PENTAX Medical ONE Pulmo.

Some of the major players operating in the market include: Boston Scientific Corporation, Ambu A/S, Verathon Inc., Olympus Corporation, Richard Wolf GmbH, KARL STORZ, FUJIFILM Corporation, Teleflex Incorporated, Medtronic, HOYA Corporation.